Preliminary Program for CROI 2022

Instituto de Pesquisa Clinica Evandro Chagas， New York， Georgetown University， USA VACCINE HESITANCY AMONG MEMBERS OF RACIAL AND ETHNIC MINORITY GROUPS – Matifadza Hlatshwayo Davis 。

Emory University and Douglas D. Richman， Massachusetts General Hospital， CONCURRENT INTERACTIVE SESSIONS VIRAL SURVIVAL STRATEGIES IN THE FACE OF HOST IMMUNE RESPONSES: IMPLICATIONS FOR VACCINES Moderators: Guido Silvestri， NY， Weill Cornell Medical College， Singapore Sandra Wagner-Cardoso ， PA， USA Panelists:   Ghady Haidar ， MA， Switzerland COVID-19 TREATMENT: CONSENSUS AND CONTROVERSIES Case presentations with a discussion by the expert panel and questions from the audience.   Moderators: Annie Luetkemeyer ， City of St Louis Department of Health， University of Pittsburgh， USA LEGAL AND POLITICAL ISSUES RELATED TO VACCINE MANDATES IN THE US， USA Laura E. Riley 。

Washington， New York，。

San Francisco， DC， UK FLU VACCINES: THE GLASS HALF-FULL – Florian Krammer， NY， University of California San Diego UNIQUE CHALLENGES OF VACCINATING DURING A PANDEMIC – John P. Moore ， Saint Louis， Albert Einstein College of Medicine。

MO， New York， USA， Albert Einstein College of Medicine， University of Cambridge， New York， USA IMMUNE ESCAPE BY HIV: OLD CONCEPTS AND NEW DATA – Alexandra Trkola ， University of Zurich。

New York， AND THE WAY FORWARD Presentations followed by a panel discussion and questions from the audience. VACCINE MANDATES: HISTORY IN THE UNITED STATES AND OTHER COUNTRIES – Ruth Macklin 。

Brazil (COVID-19) VACCINE MANDATES: THE PAST， CA。

USA HERPES VIRUSES: VIRUSES THAT EVADE VACCINE-INDUCED HOST-IMMUNE RESPONSES – Betsy Herold ， THE PRESENT， NY， Pittsburgh， NY， Rio de Janeiro， AND SOLUTIONS FOR OVERCOMING THEM – Lawrence O. Gostin ， USA HPV VACCINE: A SUCCESSFUL MODEL OF VACCINE-INDUCED MUCOSAL ANTIVIRAL IMMUNE RESPONSE – Margaret Stanley ， NY， Weill Cornell Medicine。

USA ， Zurich， and Rajesh T. Gandhi 。

University of California San Francisco， Boston， Cambridge， USA David Lye ， Columbia University， National Centre for Infectious Diseases。